TickerFacts.

A business in context

AURX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-24 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-06 · 0001437749-26-032249

  2. 8-K · Current report

    Report date 2026-09-30 · 0001437749-26-032242 · Items 1.01,2.03,3.02,9.01

  3. 4/A · Ownership change

    Report date 2026-08-27 · 0001437749-26-029257

  4. 4 · Ownership change

    Report date 2026-08-27 · 0001437749-26-029236

  5. 8-K · Current report

    Report date 2026-08-17 · 0001437749-26-028109 · Items 2.02,9.01

  6. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-028053

  7. 4 · Ownership change

    Report date 2026-06-29 · 0001437749-26-022670

  8. 4 · Ownership change

    Report date 2026-06-29 · 0001437749-26-022665

  9. 4 · Ownership change

    Report date 2026-06-29 · 0001437749-26-022664

  10. 4 · Ownership change

    Report date 2026-06-29 · 0001437749-26-022662

  11. 4 · Ownership change

    Report date 2026-06-29 · 0001437749-26-022661

  12. 8-K · Current report

    Report date 2026-05-29 · 0001437749-26-019199 · Items 1.01,2.03,3.02,9.01

  13. 8-K · Current report

    Report date 2026-05-14 · 0001437749-26-017116 · Items 2.02,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-017104

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-010360

  16. 8-K · Current report

    Report date 2026-01-21 · 0001437749-26-002078 · Items 1.01,2.03,3.02,9.01

  17. 8-K · Current report

    Report date 2025-12-16 · 0001437749-25-038091 · Items 5.07

  18. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-032437

  19. DEF 14A · Proxy statement

    Report date 2025-12-16 · 0001437749-25-032357

  20. 8-K · Current report

    Report date 2025-10-07 · 0001437749-25-030813 · Items 5.02,5.08,8.01

  21. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-024043

  22. 8-K · Current report

    Report date 2025-05-14 · 0001437749-25-017214 · Items 1.01

  23. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-013653

  24. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-010379

  25. SC 13G/A · Ownership disclosure

    0001193805-24-001361

  26. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001437749-24-034325

  27. SC 13G/A · Ownership disclosure

    0001437749-24-031767

  28. 8-K · Current report

    Report date 2024-09-18 · 0001437749-24-029602 · Items 1.01,3.02,9.01

  29. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001437749-24-025952

  30. 8-K · Current report

    Report date 2024-06-27 · 0001437749-24-021407 · Items 8.01

  31. 8-K · Current report

    Report date 2024-06-07 · 0001437749-24-019961 · Items 4.01,9.01

  32. 8-K · Current report

    Report date 2024-05-17 · 0001437749-24-017754 · Items 1.01,3.02,9.01

  33. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001437749-24-017125

  34. 10-K · Annual report

    Report date 2023-12-31 · 0001437749-24-012587

  35. 8-K · Current report

    Report date 2024-04-16 · 0001437749-24-012214 · Items 7.01

  36. SC 13G · Ownership disclosure

    0001437749-24-004098

  37. SC 13G/A · Ownership disclosure

    0001193805-24-000195

  38. SC 13D/A · Ownership disclosure

    0001437749-23-034986

  39. 8-K · Current report

    Report date 2023-12-18 · 0001437749-23-034949 · Items 1.01,3.02,9.01

  40. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001437749-23-032632

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 2 transaction rows2PSale: 0 transaction rows0SGrant / award: 7 transaction rows7AExercise / conversion: 6 transaction rows6MTax / exercise payment: 3 transaction rows3FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

18 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-28
2026-08-31 · Amendment
JORDEN DAVID EMERSONP · Purchase
Acquired
Common Stock7984.01.09
2026-08-28
2026-08-28
JORDEN DAVID EMERSONA · Grant / award
Acquired
Common Stock7984.01.09
2026-08-27
2026-08-31 · Amendment
JORDEN DAVID EMERSONP · Purchase
Acquired
Common Stock789.01.07
2026-08-27
2026-08-28
JORDEN DAVID EMERSONA · Grant / award
Acquired
Common Stock789.01.07
2026-06-30
2026-07-02
JORDEN DAVID EMERSONF · Tax / exercise payment
Disposed
Common Stock160892.01.01
2026-06-30
2026-07-02
JORDEN DAVID EMERSONM · Exercise / conversion
Acquired
Common Stock162500.01.0
2026-06-30
2026-07-02
JORDEN DAVID EMERSONM · Exercise / conversion
Disposed
Option to purchase common stock
Derivative security
162500.00.0
2026-06-30
2026-07-02
Pittman Scott M.F · Tax / exercise payment
Disposed
Common Stock39604.01.01
2026-06-30
2026-07-02
Pittman Scott M.M · Exercise / conversion
Acquired
Common Stock40000.01.0
2026-06-30
2026-07-02
Pittman Scott M.M · Exercise / conversion
Disposed
Option to purchase common stock
Derivative security
40000.00.0
2026-06-30
2026-07-02
WINZER C ERICF · Tax / exercise payment
Disposed
Common Stock39604.01.01
2026-06-30
2026-07-02
WINZER C ERICM · Exercise / conversion
Acquired
Common Stock40000.01.0
2026-06-30
2026-07-02
WINZER C ERICM · Exercise / conversion
Disposed
Option to purchase common stock
Derivative security
40000.00.0
2026-06-29
2026-07-02
CLAUSEN PETERA · Grant / award
Acquired
Option to purchase common stock
Derivative security
65000.00.0
2026-06-29
2026-07-02
JORDEN DAVID EMERSONA · Grant / award
Acquired
Option to purchase common stock
Derivative security
125000.00.0
2026-06-29
2026-07-02
Pittman Scott M.A · Grant / award
Acquired
Option to purchase common stock
Derivative security
30000.00.0
2026-06-29
2026-07-02
WINZER C ERICA · Grant / award
Acquired
Option to purchase common stock
Derivative security
30000.00.0
2026-06-29
2026-07-02
Mintz PaulA · Grant / award
Acquired
Option to Purchase Common Stock
Derivative security
30000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001091596Nuo Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • Nuo Therapeutics, Inc · former SEC name · 2014-11-13 to 2014-12-23
  • CYTOMEDIX INC · former SEC name · 2000-08-14 to 2014-10-08
  • AUTOLOGOUS WOUND THERAPY INC · former SEC name · 2000-04-12 to 2000-04-10
  • AUTOLOGOUS WOUND TRERAPY INC · former SEC name · 1999-12-10 to 2000-03-23

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$1.37M$1.47M
2023-12-31$608.5K$672.9K
2022-12-31$112.2K$129.2K
2021-12-31$0$0
2020-12-31$0$0
2019-12-31$146.2K$192.6K
2018-12-31$1.37M$1.84M
2017-12-31$721.0K$991.1K

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗